Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity

Table 1 Clinical features and follow-ups

Case	Gender	Age (years)	Specimen type	Position	Gross	Size (cm)	T	N	M	Stage^a	Pl	LVI	Treatment	Outcomes
1	M	61	Resection	Gastric body	Ulcerative	5.5	T4	1/17	0	IIIA	N	P	Surgery + chemotherapy	NED, 63 months
2	M	61	Biopsy	Gastric antrum	NA	NA	T1	NA	NA	NA	NA	NA	NA	NED, 12 months
3	M	58	Resection	Gastric antrum	Ulcerative	NA	T2	0/18	0	IB	N	N	Surgery	NED, 10 months
4	M	63	Resection	Gastric antrum	Ulcerative	3.0	T1	0/27	0	IA	N	N	Surgery	NED, 10 months
5	M	56	Resection	Gastric body	Ulcerative	2.5	T4	6/15	0	IIIA	N	P	Surgery	DOD, 42 months
6	M	68	Resection	Gastric antrum	Ulcerative	4.5	T4	28/47	0	IIIC	P	P	Surgery + chemotherapy	NED, 12 months
7	M	60	Resection	Gastric cardia	Ulcerative	2	T4	1/21	0	IIIA	P	N	Surgery	DOD, 11 months
8	M	65	Biopsy	Rectum	Fungating	5	NA	NA	1^b	NA	NA	NA	Palliative radiotherapy and chemotherapy	DOD, 12 months, liver and lung metastasis
9	M	67	Resection	Gastric cardia	Ulcerative	3.5	T3	0/16	0	NA	N	P	Surgery + chemotherapy	NED, 6 months
10	M	69	Biopsy	Rectum	Fungating	3.0	cT4	NA	1^b	NA	NA	NA	Chemotherapy	AWD, 33 months, liver metastasis

M Male, PI perineural invasion, LVI lymphovascular invasion, P positive, N negative, NA not available, AWD alive with disease, DOD dead of disease, NED no evidence of disease
^aStage is according to the AJCC 8th edition gastric cancer staging system
^bWith synchronous liver metastases

ISSN: 1475-2867